Changes in ER, PR, HER2 and Ki67 Expression in Breast Cancer after Neoadjuvant Treatment and Comparison with Clinical, Pathological Features and Ethnicity of Patients
Jamal Zidan* , Evgeny Solomonov, Wajdi Safadi, Manzooma Kablan, Timoor Daboos; Ariel Arbel; Osamah Hussei; Adi Sharabi; Sergio shvalb.
- Name: Jamal Zidan*
- Phone: +1234567890
- Country: Israel
- Received date: 02 January, 2023
- Accepted date: 01 February, 2023
- Published date: 08 February, 2023
Designation: Department of Oncology, Azrieli Faculty of Medicine, Bar-Ilan University, Israel
Citation: Zidan J, Solomonov E, Safadi W, Kablan M, Daboos T, Arbel A et al. (2023) Changes in ER, PR, HER2 and Ki67 Expression in Breast Cancer after Neoadjuvant Treatment and Comparison with Clinical, Pathological Features and Ethnicity of Patients. Int J Cancer Treat Vol: 6, Issu: 1 (01-07).
Copyright: 2023 Zidan J et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Guidelines
Subscribe
This work is licensed under a